[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100426899":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":7,"locations":8,"responsibleParty":28,"collaborators":7,"id":32,"slug":33,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":37,"acronym":38,"eligibilityCriteria":39,"healthyVolunteers":34,"sex":40,"minAge":41,"maxAge":42,"enrollmentInfo":43,"targetDuration":46,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":51,"overallStatus":11,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"Fondazione IRCCS Policlinico San Matteo di Pavia","OTHER",null,[9],{"facility":10,"status":11,"city":12,"state":7,"zip":13,"country":14,"countryCode":15,"cosmosGeoPoint":16,"geoPoint":21,"contacts":22},"Fondazione IRCCS Policlinico San Matteo","RECRUITING","Pavia","27100","Italy","IT",{"type":17,"coordinates":18},"Point",[19,20],9.15917,45.19205,{"lat":20,"lon":19},[23],{"name":24,"role":25,"phone":26,"phoneExt":7,"email":27},"Giovanni Palladini, MD","CONTACT","+390382502994","giovanni.palladini@unipv.it",{"type":29,"investigatorFullName":30,"investigatorTitle":31,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Giovanni Palladini","Principal Investigator","100426899","a-registry-of-al-amyloidosis-real-100426899",false,"NCT04839003","A Registry of AL Amyloidosis (ReAL)","A Registry to Investigate Real-world Natural History, Impact of Therapies and Patterns of Progression of AL Amyloidosis (ReAL)","ReAL","Inclusion Criteria:\n\n1. diagnosis of systemic AL amyloidosis;\n2. treatment-naïve (pre-treatment data collected at participating center available for retrospective part);\n3. age ≥18 years;\n4. ability to understand and willingness to sign an informed consent (patients who already sign informed consent for clinical data to be used in retrospective analyses will be accepted);\n5. planned (or ongoing) follow-up at participating center.\n\nExclusion Criteria:\n\n1. non-AL amyloidosis;\n2. previous treatment for AL amyloidosis.","ALL","18 Years","99 Years",{"count":44,"type":45},5000,"ESTIMATED","5 Years","OBSERVATIONAL","The purpose of this protocol is to generate a large registry of patients with AL amyloidosis.",[50],"AL Amyloidosis",[52,53,54],"amyloidosis","prognosis","registry","2026-04-13",{"date":57,"type":58},"2026-04-16","ACTUAL",{"date":60,"type":58},"2020-02-27",{"date":62,"type":45},"2027-05",{"name":5,"class":6},1]